Similar articles for PMID: 30084871

Year	Number of Results
1986	1
1993	1
1994	1
1997	1
1999	2
2002	1
2004	4
2005	6
2006	3
2007	3
2009	1
2010	2
2011	4
2012	3
2013	2
2014	7
2015	10
2016	7
2017	5
2018	10
2019	1
2023	1
2024	0

1

Reply: The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4?

Shy ME. Shy ME. Brain. 2018 Sep 1;141(9):e71. doi: 10.1093/brain/awy208. Brain. 2018. PMID: 30084871 Free PMC article. No abstract available.

2

The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4?

Vallat JM, Tazir M, Magy L, Le Masson G, Mathis S. Vallat JM, et al. Brain. 2018 Sep 1;141(9):e70. doi: 10.1093/brain/awy207. Brain. 2018. PMID: 30084872 No abstract available.

3

SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency.

Rebelo AP, Saade D, Pereira CV, Farooq A, Huff TC, Abreu L, Moraes CT, Mnatsakanova D, Mathews K, Yang H, Schon EA, Zuchner S, Shy ME. Rebelo AP, et al. Brain. 2018 Mar 1;141(3):662-672. doi: 10.1093/brain/awx369. Brain. 2018. PMID: 29351582 Free PMC article.

4

Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.

Cartoni R, Arnaud E, Médard JJ, Poirot O, Courvoisier DS, Chrast R, Martinou JC. Cartoni R, et al. Brain. 2010 May;133(Pt 5):1460-9. doi: 10.1093/brain/awq082. Brain. 2010. PMID: 20418531

5

Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.

Sevilla T, Lupo V, Martínez-Rubio D, Sancho P, Sivera R, Chumillas MJ, García-Romero M, Pascual-Pascual SI, Muelas N, Dopazo J, Vílchez JJ, Palau F, Espinós C. Sevilla T, et al. Brain. 2016 Jan;139(Pt 1):62-72. doi: 10.1093/brain/awv311. Epub 2015 Oct 24. Brain. 2016. PMID: 26497905

6

Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).

Engelfried K, Vorgerd M, Hagedorn M, Haas G, Gilles J, Epplen JT, Meins M. Engelfried K, et al. BMC Med Genet. 2006 Jun 8;7:53. doi: 10.1186/1471-2350-7-53. BMC Med Genet. 2006. PMID: 16762064 Free PMC article.

7

Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).

Piscosquito G, Saveri P, Magri S, Ciano C, Gandioli C, Morbin M, Bella DD, Moroni I, Taroni F, Pareyson D. Piscosquito G, et al. J Peripher Nerv Syst. 2016 Sep;21(3):142-9. doi: 10.1111/jns.12175. J Peripher Nerv Syst. 2016. PMID: 27231023 Free PMC article.

8

[Advances in genetic studies of Charcot-Marie-Tooth disease type 4 (CMT4)].

Xu Y, Zhang JY, Yang BY, He ZH, Zhang MC, Yu Z, Gu MM. Xu Y, et al. Yi Chuan. 2015 Jun;37(6):501-9. doi: 10.16288/j.yczz.14-412. Yi Chuan. 2015. PMID: 26351045 Review. Chinese.

9

CMT2A: the name doesn't tell the whole story.

Scherer SS. Scherer SS. Neurology. 2011 May 17;76(20):1686-7. doi: 10.1212/WNL.0b013e31821bcc42. Epub 2011 Apr 20. Neurology. 2011. PMID: 21508332 No abstract available.

10

A "nerve" ending story in the identification of mutations in Charcot-Marie-Tooth neuropathy.

Timmerman V, Herrmann DN. Timmerman V, et al. Neurology. 2006 Oct 10;67(7):1114-5. doi: 10.1212/01.wnl.0000243247.30072.a2. Neurology. 2006. PMID: 17030741 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

69 results

Results by year